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Abstract
Background. Many mathematical models characterizing mechanisms of cell fate decisions have been constructed recently. Their further study may be impossible without development of methods of model composition, which is complicated by the fact that several models describing the same processes could use different reaction chains or incomparable sets of parameters. Detailed models not supported by sufficient volume of experimental data suffer from non-unique choice of parameter values, non-reproducible results, and difficulty of analysis. Thus, it is necessary to reduce existing models to identify key elements determining their dynamics, and it is also required to design the methods allowing us to combine them.
Results. Here we propose a new approach to model composition, based on reducing several models to the same level of complexity and subsequent combining them together. Firstly, we suggest a set of model reduction tools that can be systematically applied to a given model.
Secondly, we suggest a notion of a minimal complexity model. This model is the simplest one that can be obtained from the original model using these tools and still able to approximate experimental data. Thirdly, we propose a strategy for composing the reduced models together. Connection with the detailed model is preserved, which can be advantageous in some applications. A toolbox for model reduction and composition has been implemented as part of the BioUML software and tested on the example of integrating two previously published models of the CD95 (APO-1/Fas) signaling pathways. We show that the reduced models lead to the same dynamical behavior of observable species and the same predictions as in the precursor models. The composite model is able to recapitulate several experimental datasets which were used by the authors of the original models to calibrate them separately, but also has new dynamical properties.
Conclusion.
Model complexity should be comparable to the complexity of the data used to train the model. Systematic application of model reduction methods allows implementing this modeling principle and finding models of minimal complexity compatible with the data.
Combining such models is much easier than of precursor models and leads to new model properties and predictions. 3 
Background
Systems biology aims to study complex interactions in living systems and focuses on analysis and modeling their properties. Mathematical modeling provides several ways to describe biological processes based on experimental information of different kind. However, creation of detailed models not supported by enough experimental data often makes their analysis and interpretation difficult [1] . Several aspects of the same process can be modeled using different levels of abstraction involving different reaction chains, chemical kinetics, and incomparable sets of parameters. Such models are difficult to merge. Meanwhile, merging is an important approach for creation of complex models. Thus, development of efficient methods and software, allowing us to combine models, is the object of intense study in systems biology. In our work, we focused on the fact that, generally, complexity of models is not comparable to the volume of experimental data used to adjust their parameters. Due to this fact, we turn to the methods of model reduction allowing us to minimize model's complexity without affecting the model simulation dynamics.
Model reduction is a well-established technique in many fields of biochemical research and engineering. It has been used for many years in chemical kinetics (for reviews, see [2] [3] [4] ) and has already found multiple applications in systems biology, including discrete modeling [5] and modeling of metabolic pathways [6, 7] . The principles of this technique have been applied in computational biology [8] and implemented as a part of widely used pathway simulators such as BioUML [9] , BIOCHAM [10], COPASI [11] , and GINsim [12] . Model reduction led to new insights in mechanisms of translation regulation by microRNAs [13, 14] and was applied for analysis of such signaling pathways as JAK-STAT [15] , NF-κB [16] , and EGFR [17] .
In our investigation, we used the principles of model reduction to construct reasonably accurate minimal size approximations of two different models describing the CD95 signaling pathways [18, 19] . The first model explores pro-apoptotic properties of CD95 after stimulation by its natural ligand CD95L or by agonistic antibodies anti-CD95 implying formation of the death-inducing signaling complex (DISC) [18, 20] . DISC consists of oligomerized CD95, death domain-containing adaptor FAS-associated molecule (FADD), procaspases-8 and -10, and two isoforms of cellular FLIP (CFLAR) protein (cFLIP long and cFLIP short). Caspase-8 leads to activation of effector caspase-3 directly (type I cells) or via stimulation of cytochrome C release from the mitochondria (type II cells) [21] . The latter step requires formation of the apoptosome complex and activation of caspase-9. Once activated, caspase-3 cleaves poly(ADP-ribose) polymerase (PARP), thereby making the apoptotic process irreversible. The second model describes the state when CD95 not only activates the pro-apoptotic pathway, but also induces transcription factor NF-κB that is an important regulator of cell survival functioning [19] . This is possible due to cFLIPL cleavage in the DISC complex. The cleaved p43-FLIP directly interacts with the IKK complex and activates it. The activated IKK performs phosphorylation of the IκB protein and thereby frees NF-κB.
The authors of the models have evaluated concentration changes of major apoptotic molecules by Western blot analysis and represented them as relative values at given time points. Using the systematic methodology [2] implemented in the BioUML software, we reduced the models so that they still satisfy these data. This allowed us to simplify the overlapping components of the models and find a way for their composition.
Methods

Model reduction
Mathematical modeling of biological processes based on the classical theory of chemical kinetics assumes that a model consists of a set of species ( ) associated with a set of variables ( ) ( ( ) ( )) depending on time [ ], , and representing their concentrations, and a set of biochemical reactions with rates ( ) ( ( ) ( )) depending on a set of kinetic constants . Reaction rates are modeled by mass-action or Michaelis-Menten kinetics. A system of ordinary differential equations (ODE)
representing a linear combination of reaction rates is used to describe the model behavior over time:
Here is a stoichiometric matrix of by . We say that is a steady state of the system
Model reduction implies transformation of the ODE system to another one with smaller number of equations without affecting dynamics of variables ( ) ( ), which is fixed by a set of experimental points ( ) at given times , , where is number of such points for the concentration ( ), . To check dynamics preservation in the course of model reduction, we consider the function of deviations defined as a normalized sum of squared differences [11]: Reduction of mathematical model complexity is achievable by different methods [2] .
Description of the methods used in our work is provided below.
(MR1) Removal of slow reactions. In the simplest case, one can remove a reaction which rate does not change significantly the amount of any species, during the duration T of the computational simulation (i.e., its rate v normalized on the characteristic amount of any reactant or product involved in it is much less than 1/T). In more complex case, sometimes it is possible to neglect slow reactions whose effect is dominated by faster reactions. We say that the reaction with rate ( ) is much slower than the reaction with rate
where .
If a chemical species is a reactant in two reactions and , and is much slower than , then one can test the effect of removal of , and eliminate it in some cases, if its removal does not significantly change the model dynamics. Note that it is not always possible due to existence of slowly relaxing cyclic subsystems of faster reactions, see [2] . Also note that in some cases, it is sufficient to consider or even k = 1.
Figure 1 -Schematic representation of the model reduction techniques
A model consisting of four species ( , , , and ) and two reactions ( and ) was reduced taking into account the relations between time-dependent concentrations ( ) and ( ), as well as reaction rates ( ) and ( ). In the case when ( ) ( ), the concentration of can be considered constant for some period of time. The same simplification could be applied to B.
(MR2) Quasi-steady-state (QSS) approximation [2, 16] assumes that the variables ( ) of the model can be split in two groups: "slow" basic components ( ) and fast intermediates ( ). The amounts of fast intermediates are assumed to be smaller than the amounts of basic components, while the reaction rates are of the same order, or both fast intermediates and slow components participate in the same reactions. 
∫ ( ) .
One way to perform the model reduction is to apply the foregoing methods in the numerical order ( fig.2) . Note that the methods MR5 and MR6 are of the same type, so it does not matter which one to use first. This way assumes that we calculate the value of the distance function (3) at each reduction step to test whether approximation of the experimental data is still within allowable limit or not.
Model analysis and comparison
Model comparison using Akaike information criterion (
). This criterion [24] defines the relative complexity of a model based on the goodness of experimental data fit and the number of model parameters | | (initial concentrations of species are not considered):
The function is defined by the formula (3) 
It is useful to compute the mean log sensitivity for all fitted species:
where is the number of all parameters | | or the number of parameters retained after the model reduction.
Modular modeling
Considering the mathematical models of CD95 signaling pathways [ In total, the model contains 80 reactions (Table 1) including 24 reactions based on mass action kinetics, 12 reactions taken with kinetics of Michaelis-Menten, 41 reactions of degradation, the reaction of production specified above and two reactions of cytochrome C and Smac release from the mitochondria modeled using a discrete event. The latter implies complete cytochrome C and Smac release within 7 minutes as soon as tBid reaches a certain level in comparison to Bcl-2/Bcl-XL. Since the authors did not provide exact form of the release function, we proposed the sigmoid function which has the expected behavior:
where is the time when tBid concentration reaches a value of Bcl-2/Bcl-XL, is the start time of release and is the contraction coefficient.
The model comprises 43 species (including ) and 45 kinetic parameters, which the authors estimated based on the experimental data obtained by Western blot analysis for the human cell line SKW 6.4. Cells were stimulated by 5 μg/ml and 200 ng/ml of anti-CD95 (fast and reduced activation scenarios, respectively) and dynamics of several proteins (Bid, tBid, PARP, cPARP, procaspases-2, -3, -7, -8, -9, cleaved product of procaspase-8 p43/p41, and caspases-8) were measured.
We could not reproduce the dynamics of the original model using the parameter values provided by the authors. In particular, there was too rapid consumption of procaspases-2, -3, -7, -8 in the case of 5 μg/ml of anti-CD95 and procaspases-2, -9 in the case of 200 ng/ml.
Degradation rates of procaspase-8 and caspases-8 was insufficient for both activation scenarios. Thus, we had to make several modifications of the original model to obtain the same dynamics as described in the original paper. Namely, we multiplied the rate constants of 
Reduction of the CD95-signaling model
We started the Bentele's model reduction by excluding the direct dependence of the virtual species on caspases-6 and -7. For this purpose, we approximated the amount of caspases-7 by the linear function of caspase-3 concentration:
where for both activation scenarios. In addition, we considered inequalities holding for the parameters in the formula (10):
and simplified it:
After that we decomposed the model into modules (fig. 3B) corresponding to three biological steps: activation of caspase-8, cytochrome C-induced activation of caspase-9 and PARP cleavage down-regulated by these caspases.
Below we provide detailed description of the reduction process of all modules. The process is based on the flow chart represented in the figure 2. If it is enough for a reader to have a general idea of model reduction without going into full details, we suggest to go directly to the last two paragraphs of this section, where you find the summary of the model reduction procedure.
Caspase-8 activation module includes 20 species and 14 reactions (besides the reactions of degradation), which could be divided into three groups: cleavage of procaspase-8 at the DISC complex, its activation triggered by caspase-3, and inhibition of complexes containing DISC by cFLIPL and cFLIPS (Table 1, fig. 3A , reactions br1-br14).
Firstly, we eliminated slow reactions br12 and br13 according to the method MR1. Next, we applied the quasi-steady-state analysis (MR2) to the module and removed quasi-stationary intermediates CD95R:CD95L, DISC:pro8, DISC:pro8 2 , DISC:p43/p41 and DISC:cFLIPL.
Thus, in particular, we got two main reactions instead of br1-br6: fast formation of the DISC complex (Table 1, fig. 3B , br1*) and slower activation of caspase-8 in this complex (br2*).
Further, we noticed that the consumptions of cFLIPL and cFLIPS satisfied the same kinetic laws. Therefore, these species could be lumped (MR3) resulting in the reaction br4*:
where cFLIP indicated two isoforms cFLIPL and cFLIPS so that . We approximated the concentration of caspase-6 by the linear function , (MR4), and merged reactions br7 and br8 of caspases-8 activation induced by caspases-3 and mediated by caspases-6 into one reaction br3*:
pro8 -casp3 → casp8.
Since the reaction br8 followed the Michaelis-Menten kinetics with the constants and , then the reaction rate of br3* was provided by the kinetic law Complementing the above reduction steps, we removed the elements that were unnecessary to fit the experimental dynamics provided by Bentele et al. These elements were degradation reactions of CD95L, CD95R and FLIP, and the blocked DISC complex (inactivated DISC). As a result, we introduced the conservation law:
where and denote initial concentrations of the ligand and receptor, respectively.
Solving the differential equation
we obtained the analytical function for the receptor concentration:
The module of caspase-9 activation consisted of 19 species and 14 reactions (besides the reactions of degradation) including activation of caspase-9 triggered by cytochrome C, cleavage/activation of Bid by caspases-2 and -8, IAP inhibition of caspase-9 activity and binding of inhibitors by Smac (br15-br26, br35, br38). Based on the method MR1, we eliminated the last two reversible reactions, as well as the slow reaction br20 of the apoptosome complex dissociation. Further, since this complex was a quasi-stationary intermediate and the rate of br15 was linearly dependent on a difference of br16 and br17
rates, we reduced the chain of procaspase-9 activation (br15-br20), using the methods MR2
and MR4, to the form: 
Solving it, we found:
Finally, analyzing reactions of Bid activation (br21-br23), we removed the slower reaction mediated by caspase-2. The similar reaction involving caspase-8 followed the MichaelisMenten kinetics with the constant . Therefore, we redefined the kinetics of this reaction based on the law of mass action (MR5):
⁄
The module of PARP inactivation contained 13 species (including the virtual species ) and 11 reactions (excepting reactions of degradation). Six reactions (activation of caspases-3
and -7 by caspases-8 and -9, and cleavage/inactivation of PARP) were based on the Michaelis-Menten kinetics (br27-br32), four reactions reproduced the reversible inhibition of caspases-3 and -7 based on the law of mass action (br33, br34, br36, br37), and one corresponded to the production of (br38), simplification of which was discussed above.
We deleted slow reactions of casp3:IAP and casp7:IAP complexes dissociation and ignored slow degradation of procaspase-7 and IAP. Then analyzing the cleavage of procaspases-3 and -7, we eliminated reactions triggered by caspase-9, which were slower in comparison to the similar reactions induced by caspase-8. For the same reason we ignored the reaction of PARP inactivation by caspase-3 (MR1).
Considering the remaining reactions with the Michaelis-Menten kinetics (br29, br32), we used the following inequalities and , which, in combination with MR5 and (12), led to the following kinetic laws:
Thus, the CD95-signaling model consisting of 43 species (including one virtual species), 80 reactions and 45 kinetic parameters was approximated by a model with 18 species, 26
reactions and 25 parameters, except the constant concentration of Cytochrome C ( fig. 3C ). Species without experimental evidence (CD95L, DISC, cFLIP, DISC:pro8:cFLIP, IAP, caspase-3 and virtual species ) and reactions br1*-br13* directly affect the simulated dynamics of the experimentally measured concentrations (Table 2) . Thus, further reduction of the model by removing these elements is impossible. Regarding the degradation process, we agree with Bentele et al. that experimental data cannot be matched if this process is fully ignored. Actually, if we remove any of the retained reactions of degradation, then excepted concentration dynamics will be impaired. Thus, we found the minimal complexity approximation of the original model.
Reduction of the CD95-mediated and NF-κB signaling model
As was mentioned above, Neumann et al. simplified their model in order to reduce the large number of free parameters. The authors noted that further simplification of the model was not possible because the model fit significantly decreased. However, we removed slow reactions (nr4, nr11-nr13, fig. 4A ) using the method MR1, and removed the reaction of NF-κB degradation (nr23), which was not significant for reproducing the experimental data of the original model. Note that we retained the slow reactions nr6 and nr7, the former of which regulates apoptosis inhibition in the case of high levels of cFLIPL and procaspase-8 in accordance with the precursor model prediction (see the analysis of the predictions below), and the latter of which will be required to combine this model with the Bentele's model hereafter.
Based on the method MR6, we also took into account the inequality and simplified the kinetic law of the reaction nr19 to the form ( ) Therefore, we reduced the number of model species from 23 to 20, the number of reactions from 23 to 18 and the number of kinetic parameters from 17 to 15 (besides the constant concentration of IKK). These modifications did not change the fit to the experimental data provided by Neumann et al. (Figure 6 ).
Model composition
Analysis of the reduced models based on the Akaike criterion (7) confirmed that they had lower complexity than the original models (table 3) . The difference between the mean coefficients (8) of the models decreased by 60%, relative to the initial value. In addition, the reduced Neumann's model better approximated experimental data. Therefore, we used it as the basis for the model composition.
We took into account that the considered experimental data were obtained with SKW 6.4
[ We constructed the composite model of CD95 and NF-κB signaling in the following way.
Firstly, according to the assumption (C), we replaced reaction nr15 in the Neumann's model by a chain of three reactions:
Bid -casp8 → tBid, pro9 -tBid → casp9, pro3 -casp9 → casp3.
(17) Wherever blue or black dots are missing, they coincide with the red dots. Note that considering the concentration of procaspase-8 in the original model, we observed experimental dynamics for the separate species only, but not for the total amount as expected from experiments. Thus, validating parameters of the composite model, we evaluated the total amount of procaspase-8. The modules of caspase-8 and NF-κB activation were taken from the reduced Neumann's model and combined with the modules of caspase-9 activation and PARP inactivation isolated from the reduced Bentele's model. In addition, two last modules were supplemented by reactions from the modified module of caspases-3 activation. fig. 5, 6 ).
Calculation of the mean coefficient for this model revealed that it has the same level of complexity as the reduced models (Table 3) . We also noted that reduction of both models did not significantly alter the steady-state concentrations (Tables 5S-6S) 
Model composition modifies some properties of the precursor models and leads to new predictions
Considering the predictive ability of the composite model, we found that in the case of HeLa cells it was completely preserved (table 5).
In the case of SKW 6.4 cell line, we estimated the value of degradation rate parameter based on the experimental observations by Bentele et al. for 1-10 ng/ml of anti-CD95 (table   6 ). When performing simulation experiments of the model for this cell line, we used three different values of depending on whether the initial concentration of CD95L was within the range 1-100 ng/ml, within the range 100-1000 ng/ml or greater than 1000 ng/ml (table   3S ). Analyzing the model predictions, we detected differences in the behavior of the Bentele's and the composite models (table 6 ). The first of them describes a threshold mechanism for CD95-induced apoptosis implying that this process is completely stopped when CD95L concentration is below the critical value. However, the model predicts a sharp increase of cPARP immediately when the level of CD95L exceeds the threshold (table 6, № 1). In contrast, the composite model shows a gradual increase of cPARP with increase of the ligand level. To determine the apoptotic threshold in this case, we found concentration of CD95L for which cPARP ratio is equal to 10% of the initial PARP amount [30] . As in the original model, this concentration was in the range of 1-10 ng/ml. Additionally, the models revealed sensitivity of the threshold to the concentration of cFLIP (table 6, 
Limitations of the composite model
We analyzed a set of parametric constraints which allowed us to reduce the precursor models ( 
Discussion
In this paper, we considered two approaches to development of mathematical models of cell fate decisions. The first concerns the methodology of model reduction and involves approximation of one model by another one of lower dimension without affecting dynamics of experimentally measured species. The second implies composition of the models and aims at reproducing experimental dynamics of all precursor models.
There are many advantages of working with low-dimensional models [8] .  choice of elements in the overlapping parts of different models;
 incomparable sets of parameters;
 the lack of experimental data, as well as inability to use the data obtained for different cell lines or in different ways (e.g. single-cell or cell culture measurements);
 inability to make accurate predictions.
Model reduction allows solving some of these problems. In particular, reducing the number of model elements, we reduce the overlapping parts as well. This may be essential for direct combining of models. In addition, the complexity of the reduced model become comparable with the complexity of available experimental data. Therefore, the risk of model overfitting is decreased.
In the case when two models are directly related (for example, one model was emerged Another quite useful principle that we used in modeling was modular structure of the developed model. This principle provides flexibility for future extensions. Thus, we are planning to extend the composite model and supply it with modules and data from studies of TRAIL [31] [32] [33] and TNF-α [34, 35] signaling, apoptosome-dependent caspase activation [36] and p53 oscillation system [37] . 
Conclusions
Mathematical modeling provides a powerful tool for studying the properties of biological Tables   Table 1 -Summary of 
№
The composite model behavior Predictions by Neumann et al.
1*
The concentration of anti-CD95 required for the apoptosis induction (the apoptotic threshold), is within the range of 30-100 ng/ml. This range remains the same for CD95 decreased by about 12-fold.
The simulation time, which we used to reproduce this prediction, was 60 hours.
2*
The decreased receptor number results in impairment of both CD95-and NF-κB-signaling pathways. To test this prediction, Neumann et al. considered levels of caspases-8 cleavage and IκB-α degradation for the original (solid lines) amount of CD95 and the amount decreased by about 12-fold (dashed lines). The concentration of anti-CD95 was 500 ng/ml.
3*
Along with increasing the concentration of anti-CD95 from 500 ng/ml to 1500 ng/ml, p43/p41 peaks earlier, while there is almost no difference for p43-FLIP.
4
Increased concentrations of cFLIPS inhibit both apoptotic and NF-κB pathways, although p43-FLIP generation is inhibited at a lower threshold than p43/p41 generation.
5*
Increasing the concentration of cFLIPL leads to a steep increase in p43-FLIP generation until it reaches a maximum, after which the curve drops. Lowered levels of cFLIPL result in very little p43-FLIP but almost unchanged levels of p43/p41.
At very high concentrations of cFLIPL no p43-FLIP is generated. This drop-off was not observed experimentally by the authors. All the predictions marked with an asterisk were experimentally tested by Neumann et al. and confirmed, unless otherwise noted. The simulation time in predictions 3-7 was 360 min. The concentration of anti-CD95 considered by the authors in predictions 4-7 was 1000 ng/ml.  for 1 ng/ml of anti-CD95, PARP cleavage was not observed;
 the measured death rate for 10 ng/ml of anti-CD95
was 20-30%.
Original model (red):
 the apoptotic threshold is 1.9 ng/ml;  cPARP concentration rises dramatically within an extremely narrow interval of anti-CD95 levels overcoming the apoptotic threshold.
Composite model (blue):
 the apoptotic threshold is 3.5 ng/ml;  cPARP concentration rises in a smooth manner along with the increase of anti-CD95 level.  the apoptotic threshold is highly sensitive to the concentration of cFLIP;
 decreasing the initial concentration of cFLIP by more than 51% and 49% for the original and composite models, respectively, leads to cell death upon stimulation by 1 ng/ml of anti-CD95.
3
Experiments by Bentele et al.: in the 10 ng/ml activation scenario, a significant increase of caspase-8 was observed after more than 4 hours. Original (red) and composite (blue) models: anti-CD95 concentrations which are slightly above the apoptotic threshold result in caspase-8 activation after a delay of many hours.
The figure shows peak times of caspase-8 concentration exceeding 0.1% of the initial procaspase-8 level. The simulation time was 2880 min (2 days) in all predictions. The apoptotic threshold in the prediction 1 is the concentration of anti-CD95 after which cPARP amount exceeds 10% of the initial PARP level. 3 
1*
2*
3*
4
Increased concentrations of cFLIPS inhibit both apoptotic and NF-κB pathways, although p43-FLIP generation is inhibited at a lower threshold than p43/p41 generation. 
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5*
At very high concentrations of cFLIPL no p43-FLIP is generated. This drop-off was not observed experimentally by the authors.  for 1 ng/ml of anti-CD95, PARP cleavage was not observed;
Original and reduced models:
 the apoptotic threshold 5 is 1.9 and 6.9 ng/ml for the original and reduced models, respectively;  cPARP concentration rises dramatically within an extremely narrow interval of anti-CD95 levels overcoming the apoptotic threshold.
Composite model:
 decreasing the initial concentration of cFLIP by more than 51%, 86% and 49% for the original, reduced and composite models, respectively, leads to cell death upon stimulation by 1 ng/ml of anti-CD95.
3
Experiments by Bentele et al.: in the 10 ng/ml activation scenario, a significant increase of caspase-8 was observed after more than 4 hours. All models: anti-CD95 concentrations which are slightly above the apoptotic threshold result in caspase-8 activation after a delay of many hours.
The figures show peak times of caspase-8 concentration exceeding 0.1% of initial procaspase-8 level. 
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